| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.1 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.1 |